Huang Shih-Han S, Filler Guido, Lindsay Robert, McIntyre Chris W
Department of Medicine, Division of Nephrology, Western University and London Health Sciences Centre, London, Canada; Department of Medical Biophysics, Western University, London, Canada; Department of Pediatrics, Western University, London, Canada.
Semin Dial. 2015 Jan-Feb;28(1):1-5. doi: 10.1111/sdi.12317. Epub 2014 Oct 27.
Dialysis patients have high mortality rate and the leading cause of death is cardiovascular disease. Uremic cardiomyopathy differs from that due to conventional atherosclerosis, where cardiovascular changes result in ineffective circulation and lead to tissue ischemia. Modern dialysis has significant limitations with fluid management probably the most challenging. Current evidence suggests that both volume overload and aggressive fluid removal can induce circulatory stress and multi-organ injury. Furthermore, we do not have accurate volume assessment tools. As a result, targeting euvolemia might result in more harm than benefit with conventional hemodialysis therapy. Therefore, it might be time to consider a degree of permissive over-hydration until we have better tools to both determine ideal weight and improve current renal replacement therapy so that the process of achieving it is not so fraught with the current dangers.
透析患者死亡率很高,主要死因是心血管疾病。尿毒症性心肌病与传统动脉粥样硬化所致的心肌病不同,后者心血管变化会导致循环功能不全并引发组织缺血。现代透析存在显著局限性,其中液体管理可能是最具挑战性的。目前的证据表明,容量超负荷和积极的液体清除均可诱发循环应激和多器官损伤。此外,我们没有准确的容量评估工具。因此,对于传统血液透析治疗而言,将目标设定为血容量正常可能弊大于利。所以,在我们拥有更好的工具来确定理想体重并改进当前的肾脏替代治疗,以使实现理想体重的过程不再充满当前这些风险之前,或许是时候考虑一定程度的允许性水钠潴留了。